LUNCH IS ON US!

This meeting may be virtual, but your lunch hour isn't! All participants who attend one of the webinars listed below and complete the online posttest and evaluation form will receive a $25.00 Uber Eats e-gift card* compliments of Integritas Communications.

Target Audience

The educational design of this activity addresses the needs of community-based allergy/clinical immunology, medical dermatology, hematology/oncology, and gastroenterology clinicians (MDs, NPs, PAs) involved in the management of patients with nonadvanced systemic mastocytosis (SM).

Program Overview

SM is a rare and underrecognized clonal mast cell disorder that often presents with heterogeneous symptoms, leading to diagnostic delays, significant quality-of-life burdens, and suboptimal care. This BRIDGE SM regional webinar series is designed to close critical knowledge gaps among community-based clinicians involved in the diagnosis and management of nonadvanced SM. Through an in-depth review of pathophysiology, clinical presentation, diagnostic tools, and treatment options—including US Food and Drug Administration (FDA)-approved targeted therapies—participants will gain actionable insights into improving patient outcomes. Regional perspectives will highlight how SM diagnosis and care pathways may vary across diverse practice settings and geographic areas in the US.

Educational Objectives

After completing this activity, the participant should be better able to:

1. Describe the pathophysiology of nonadvanced SM, including the role of driver mutation(s) in mast cell activation, their impact on multisystem clinical manifestations, and the rationale for targeted therapies clinical manifestations
2. Utilize updated diagnostic criteria and laboratory assessments, including molecular and ancillary testing, to differentiate indolent and other forms of SM for accurate disease classification and prognosis
3. Summarize clinical trial findings for emerging and established therapies, including FDA-approved treatments
4. Develop individualized treatment plans for patients with nonadvanced SM by incorporating clinical evidence, safety considerations, patient-reported outcomes, shared decision-making, patient education, and multidisciplinary management

You are welcome to attend the webinar that best fits your schedule, keeping in mind there will be region-specific nuances included in each of the presentations.

*The $25.00 Uber Eats e-gift card will be reported as a payment or transfer of value (PVOT) as defined by the Physician Payment Sunshine Act.